Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In April 2021, the FDA approved the 100th monoclonal ...

For therapies based on monoclonal antibodies (mAbs), bioprocessors continually search for ways to improve the development process. Machine learning (ML) offers one useful tool. As Mariano Nicolas Cruz ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. Antibody-drug conjugates (ADCs) are promisingly emerging cancer therapies that ...

Partnership has already generated high-quality, AI-ready data in less than three months MOUNTAIN VIEW, CA / / January 8, 2026 / AbTherx today announced a therapeutic antibody discovery and ...

Antibodies play a vital role in the immune system by providing protection against foreign invaders, such as bacteria and viruses. Produced by B cells, antibodies are protein molecules that can be ...

The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...

FDA Clears IND Allowing Phase 2a Trial of NAV-240 in Hidradenitis Suppurativa to Begin Dosing in Q1 2026HREC Approval ...

Austin, Texas, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Antibody Discovery Market Size & Growth Analysis: According to SNS Insider, the Antibody Discovery Market size was valued at USD 8.42 billion in 2024 ...